Other MDM2 antagonists which have been demonstrated anticancer activity in NB models include SAR405838 (MI‐77301),216 MK‐8242,217 MI‐63,218 RG7112,219 and RG7775.220. This evidence concerns the gene MDM2 and neuroblastoma.